You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
2 February 2026 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (NYSE: AZN) reported on Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Imfinzi (durvalumab)...
2 February 2026 - I Peace Inc, a California-based GMP cell therapy CDMO, announced on Friday that it has generated human induced pluripotent stem (iPS) cells from NKT cells and has started offering them for research use.NKT cells are immune cells kno...
2 February 2026 - Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Friday that it is planning to invest over USD3.5bn in a new manufacturing facility in the Lehigh Valley, Pennsylvania.Serving as Lilly's newest injectable med...
2 February 2026 - Frontage Laboratories Inc, a US-based global Contract Research, Development and Manufacturing Organisation (CRDMO) and a subsidiary of Frontage Holdings Corporation (HKEX:1521), said on Friday that it has expanded its early phase cl...
30 January 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) said on Friday that it has entered into a strategic collaboration with CSPC Pharmaceuticals to advance eight programmes targeting obesity and type 2 diabetes...
30 January 2026 - Biotechnology company Repertoire Immune Medicines announced on Thursday that it has entered into a strategic collaboration with pharmaceutical company Eli Lilly and Company (NYSE:LLY) to develop tolerizing therapies for multiple aut...
30 January 2026 - Formation Bio, an AI-native pharma company, and Chinese pharmaceutical company Jiangsu Chia Tai Feng Hai Pharmaceutical Co Ltd (CTFH) announced on Thursday that Formation Bio has acquired worldwide rights, excluding Greater China, t...